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Abstract
Structural magnetic resonance imaging (MRI) has shown great utility in diagnosing soft tissue burden in osteoarthritis
(OA), though MRI measures of cartilage integrity have proven more elusive. Sodium MRI can reflect the proteoglycan
content of cartilage; however, it requires specialized hardware, acquisition sequences, and long imaging times. This
study was designed to assess the potential of a clinically feasible sodium MRI acquisition to detect differences in the
knee cartilage of subjects with OA versus healthy controls (HC), and to determine whether longitudinal changes in
sodium content are observed at 3 and 6 months. 28 subjects with primary knee OA and 19 HC subjects age and
gender matched were enrolled in this ethically-approved study. At baseline, 3 and 6 months subjects underwent
structural MRI and a 0.4ms echo time 3D T1-weighted sodium scan as well as the knee injury and osteoarthritis
outcome score (KOOS) and knee pain by visual analogue score (VAS). A standing radiograph of the knee was taken
for Kellgren-Lawrence (K-L) scoring. A blinded reader outlined the cartilage on the structural images which was used
to determine median T1-weighted sodium concentrations in each region of interest on the co-registered sodium
scans. VAS, K-L, and KOOS all significantly separated the OA and HC groups. OA subjects had higher T1-weighted
sodium concentrations, most strongly observed in the lateral tibial, lateral femoral and medial patella ROIs. There
were no significant changes in cartilage volume or sodium concentration over 6 months. This study has shown that a
clinically-feasible sodium MRI at a moderate 3T field strength and imaging time with fluid attenuation by T1 weighting
significantly separated HCs from OA subjects.
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Introduction
Knee osteoarthritis (OA) is a debilitating disease with
cartilage degeneration as a major feature of the disease
process. The standard assessment of efficacy of OA therapies
for regulatory agencies is via radiographs taken over a period
of one or more years [1]. There is considerable interest in
methodologies which could give a reliable indication of
cartilage degradation or preservation over short timescales in
order to evaluate new interventions and pharmaceutical
therapies. Disappointingly, average cartilage volume change as
detected by structural MRI was only 4-6% per year [2], with no
consensus on measurement or analysis methodology. MRI
measures of cartilage integrity have focused on T2 [3], T1rho
[4], and the delayed gadolinium enhancement MRI of cartilage
(dGEMRIC) [5]. Interpretation of T2 changes is complicated by
sensitivity to collagen degradation, tissue hydration, and fibril
orientation [6], while T1rho is known to be sensitive to several
macromolecular components [6].
Sodium MRI has shown promise as a technique to image the
integrity of articular cartilage in vivo [7,8]. Mobile ions such as
sodium will distribute in cartilage in proportion to the
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proteoglycan concentration, relatively unaffected by the sodium
content or inflammation of the synovium [9]. In cartilage
samples, sodium imaging has been shown to be sensitive to
small changes in proteoglycan concentration [7,8].
Unfortunately, sodium MRI requires specialized hardware and
software, and the low innate signal to noise ratio (SNR) of
sodium MRI demands long imaging times. Current sodium MRI
methods [10–12] have focused on sodium-density weighted
imaging, requiring long TRs in order to assure full T1 recovery
of all species. Further, inversion-recovery (IR) based sodium
MRI has now been explored to remove the synovial fluid
component [13–15] which can affect the measured cartilage
sodium concentration by the partial voluming effect of the low
resolution achievable in sodium MRI. The major drawback of
these IR methods are a 40% loss of SNR [15], or equivalently
half the SNR efficiency [16], which requires twice the scan time
in order to recover the lost SNR.
As the sodium T1 at 3T of synovial fluid is around 60ms but
only 18ms in cartilage [8,17,18], a T1-weighted short TR
sequence would preferentially attenuate the fluid signal over
the cartilage signal. Furthermore, the SNR per unit time could
be increased by up to 50% [19]. To this date, no study has
examined the ability of T1-weighted sodium MRI to map
longitudinal and cross-sectional differences in the knee
cartilage in OA. Therefore, the aim of the study was to assess
differences at baseline in the sodium content of the knee
cartilage of OA subjects (OAs) to that of healthy controls (HCs)
matched for age and gender as determined by T1-weighted
sodium MRI. A further aim was to determine whether changes
in cartilage integrity, as indicated by changes in sodium
content, are observed at 3 and 6 months in order to determine
the utility of sodium MRI as an endpoint for clinical drug trials.
Methods
Patient Population
A total of 31 OA subjects with documented diagnosis of knee
OA meeting the 1986 American College of Rheumatology
(ACR) criteria for primary knee OA [20] were recruited from
rheumatology and surgical clinics within Imperial College NHS
trusts hospitals into the OA cohort. Three subjects withdrew
after screening and enrollment but before any imaging
sessions, resulting in 28 complete datasets in the OA group. A
total of 23 healthy subjects were also recruited into the HC
cohort, each healthy subject recruited to age (± 5 years) and
gender match an OA subject. Four subjects withdrew in the HC
group, resulting in 19 complete datasets in healthy subjects.
Healthy subjects were defined as individuals who were free
from clinically significant illness or disease as determined by
their full medical history (including family), physical
examination, and previous laboratory studies. Sample sizes
were determined based on the effect size seen in previous
small cohort studies [17]. All subjects were recruited and gave
written informed consent in accordance with a research ethics
committee approved (Redbridge and Waltham Forest REC ref:
08/H0701/87) study protocol.
All subjects attended the baseline visit within 28 days of the
screening visit, followed by visits at 3 months and 6 months
post-baseline. During each visit subjects underwent clinical
assessments including a pain visual-analog scale (VAS) score,
the International Physical Activity score (IPAQ) [21], and the
Knee injury and Osteoarthritis Outcome Score (KOOS) [22].
Following this, subjects had a single MRI scanning session. All
subjects also had standing plain film x-rays taken at the
baseline visit only, and whole joint Kellgren-Lawrence scores
[23] were derived by a radiologist with 16 years’ experience,
blinded to the subjects’ cohort.
Phantom Imaging
A range of sodium gel phantoms were created in 50mL
plastic tubes. Five 10% by weight agar phantoms were
constructed with 150, 200, 250, 300, and 350mM sodium
concentration to mimic healthy cartilage [8]. In addition, 300mM
sodium phantoms were also constructed with 4%, 6%, and 8%
by weight agar to mimic partially degraded cartilage, which may
be expected to have longer sodium T1 and T2 relaxation times
[18] [8]. Finally, 0% by weight agar (saline) phantoms were
constructed with a stronger 250mM concentration as well as
150mM sodium to mimic synovial fluid.
MR Imaging
Phantoms and subjects were scanned in a Siemens 3T Tim,
a Trio System (Siemens Healthcare, Erlangen, Germany) MRI
scanner in all three visits with an 18cm diameter dual tuned
proton-sodium quadrature volume coil (Rapid Biomedical
GmbH, Rimpar, Germany) positioned at the magnet’s
isocentre.
Sodium MRI images were acquired using an ultra-short TE
3D cones [11,24] readout. 712 3D cones readouts of 1052
readout points were acquired per volume for a final isotropic
resolution of 2.5mm in an 18cm FOV, TE=270µs, and a
nominal flip angle of 70°, with 118 averages. Subjects were
imaged with a T1-weighted acquisition using a TR of 15ms,
requiring 21 minutes. Phantom experiments used an identical
setup, but were imaged with a range of TRs: 15ms, 30ms,
50ms, and 100ms, requiring 21, 42, 70, and 140 minutes,
respectively.
High resolution 3D structural dual-echo steady state (DESS)
[25] was acquired at 600µm isotropic resolution in 6m: 34s in
160 slices in a 3D sagittal slab with 15cm FOV using a TR of
14.84ms, TE of 5.04ms, and a 25° water-excitation RF pulse.
Structural scans were also acquired at baseline and were
reviewed to exclude other knee pathologies. Two of the
phantoms with 150 and 250mM sodium concentration were
included in the field of view for all scans for signal
normalization.
Sodium images, [Na], were corrected for partial recovery of
the sodium signal using the median signal in the ROI covering,
T1 of, and known concentration in the stronger of the two
reference vials in the in-vivo images and the 250mM 10% agar
vial in the phantom images, SVIAL, T1vial, and [Vial], respectively,
as well as a literature T1 value for sodium in the cartilage,
T1CART, at 3T of 18ms [8,17,18] using:
Sodium MRI of Cartilage in Osteoarthritis
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e73067
ROI Definition
The cartilage was segmented on the 3D 1H DESS images by
a blinded reader into three large cartilage zones: tibial, femoral
and patellar. Each region was sub-divided into medial and
lateral zones: medial-tibial (MT), lateral-tibial (LT), medial-
femoral (MF), lateral-femoral (LF), medial-patellar (MP) and
lateral-patellar (LP). The tibial and femoral cartilage was
divided into medial and lateral using the midline of the
intratrochanteric fossa. The patellar cartilage was split by a
vertical line halfway between the medial border of the lateral
femoral condyle and the lateral border of the medial femoral
condyle. Volumes for each ROI were generated for each
timepoint. The sodium MR image was co-registered using the
rigid-body registration in spm8 (FIL, Institute of Neurology,
London, UK) to correct for any patient movement between the
scans. Median sodium concentrations in each ROI were
calculated for each sodium scan.
In phantom experiments, ROIs were drawn in each sodium
phantom, and the mean over each ROI was reported.
Statistical Analysis
Repeated measures ANOVA was used on all MRI measures.
Separate analyses were run for the volume and median Na
concentration for the three different levels of ROIs (whole knee,
3 ROIs, 6 ROIs) making a total of six models. Within each
model fixed effect terms were included for group, visit and ROI
(aside from the whole knee analysis) and all corresponding 2-
and 3-way interactions. Random effects were included for
subject and matched-pair. Where applicable the ROIs were
considered a repeated measure within each visit with an
unstructured correlation matrix. The overall statistical
significance of variation between levels of fixed effects (main
effects and interactions) was assessed using an F-test applying
the Kenward-Rogers correction to the denominator degrees of
freedom. Where applicable the statistical significance of
pairwise differences between levels was assessed using a t-
test. Spearman’s rank correlation coefficients between the
primary and secondary endpoints were estimated with 95%
confidence intervals (CIs). A non-parametric measure of
association was used to avoid assumptions of linear
relationships. The Student’s t-test was used to analyze group
differences in body mass index (BMI), height, weight, and
KOOS scores. Gender was compared with Fisher’s exact test,
and the Wilcoxon signed-rank test was used on K-L scores.
Results
Clinical Measures
Baseline comparisons between groups are reported in Table
1. The two groups are almost perfectly age-matched, although
the protocol allowed a per-subject deviation of up to 5 years.
The OA group was highly significantly separated (p=0.0016)
from the HC group by KL score, a well-established method of
assessing joint degradation radiographically. KOOS and pain
scoring systems were still more discriminating between groups
(p<0.0001), which may be expected as pain is one of the ACR
criteria for OA diagnosis. The IPAQ scoring did not achieve
significance (defined as p<0.05), possibly as it only reflects
activity levels. The OA group was heavier than the HC group,
with a mean BMI of 29.6 versus 24.9 for the HC group. This
may be a result of limited mobility due to knee OA.
Among the pair-wise associations between subjects’ clinical
assessments, four of the measures had rank correlations (r) ≥
0.3. Age was correlated with K-L score but did not achieve
significance (r=0.30, p=0.096). However, KOOS did achieve
significance with K-L score (r=0.51, p=0.0028), as did the pain
VAS (r=0.43, p=0.014). KOOS and the pain VAS were well
correlated (r=0.89, p<0.0001), which could be anticipated given
that pain scores make up part of the KOOS index.
MRI Measures
Figure 1 displays the results of the phantom imaging
experiments. Each phantom vial has four plot marks, one for
each TR used (15, 30, 50, and 100ms) in lightening colors with
lengthening TR. The uncorrected signal level in the cartilage-
mimicking 10% agar solution vials follows a linear trend versus
known sodium concentration (R2=0.984) regardless of TR
used. However, the signal level, and thus measured sodium
concentration, of the synovial fluid-mimicking saline solutions
(circles in Figure 1) is depressed. The 15ms TR in the darkest
plot symbols, as used in the clinical imaging, underestimates
the sodium concentration in saline by almost 50%. Synovial
fluid has a lower sodium concentration of 150mM versus the
concentration in healthy cartilage of 250 to 300mM [8,26].
Therefore, in the clinical imaging, synovial fluid sodium signal
intensity would be very hypointense. The decreasing agar
concentrations increased the underestimation of the sodium
signal, as expected. The 8% agar solution of 300mM sodium
underestimates the sodium concentration by only 4.25% versus
the 10% solution, whereas the 4% solution underestimates by
35%.
Figure 2 demonstrates the 3D UTE T1-weighted sodium
concentration imaging overlaid on the 3D DESS image for an
OA subject. High sodium concentration (red) can be
appreciated in the cartilage. Table 2 reports the average values
for volume and median Na concentration with standard errors
found across each cohort for each of the three visits. Values
are first reported for the whole-cartilage ROI, and then
subdivided into the femoral, patellar, and tibial regions, before
the medial and lateral subdivisions of the three regions. Table 3
Table 1. Summary of the clinical measures in the two
subject groups at baseline.
 OA Subjects  Healthy Controls
 n mean SD min max  N mean SD min Max p-value
Age 28 63 9 43 81  19 62 7 50 72 0.93
Height (cm) 28 162.7 9.4 150 186  19 166.0 7.8 155 178 0.195
Weight (kg) 28 78.0 15.1 53.5 100  19 68.9 10.2 49.5 85.5 0.017
BMI 28 29.6 5.8 19.2 37.7  19 24.9 2.5 19.8 28.3 0.0005
K-L score 27 2.1 1.2 0 4  18 0.6 0.7 0 2 0.0016
KOOS 28 129 30 76 189  19 39 14 0 53 <0.0001
IPAQ 28 2.6 1 1 3  19 2.8 0 2 3 0.10
Pain VAS 28 7.3 3 0 10  19 0.3 1 0 3 <0.0001
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 summarizes the statistically significant (p<0.05) findings from
Table 2 with the six ANOVA models. There was a 20% smaller
patellar cartilage volume in OA subjects compared to healthy
controls, which was strongly significant. The femoral cartilage
was slightly (8.2%) larger in OA subjects, but this did not reach
significance. As expected from prior work, there were no
significant changes in volume with time for either group over
this 6 month period.
Values reported are the mean (standard error) across
subjects.
Median sodium concentration in the femoral and tibial ROIs
was greater than in the patellar ROI by 21%. OA subjects had
an 8% higher sodium concentration in the whole knee than
HCs, with this increase most strongly observed in the lateral
tibial (18% higher), lateral femoral (12% higher) and medial
patellar (11% higher) ROIs, all of which were significant. There
were no significant changes in concentration over time for OA
subjects or HCs. The stability of the sodium concentration
across time, as well as the separation between groups, can be
appreciated graphically in Figure 3, which plots the average of
each group’s sodium concentration at all three visits. At all
timepoints, in all 3 ROI regions as well as the whole knee, OA
subjects had a stronger sodium concentration than HCs.
Medial and lateral delineated ROIs follow similarly (data not
shown).
Figure 1.  Sodium concentrations measured with 3D UTE imaging of sodium phantoms across varying TRs.  The lightest
plot symbols correspond to a 100ms TR, darkening with as drops to 50ms, 30ms, and finally 15ms for the darkest plot symbols. All
data has been corrected for the incomplete T1 relaxation of cartilage sodium using the 250mM cartilage-mimicking 10% agar
phantom. A strong linear relationship between image intensity and mean sodium concentration is found in the 10% agar cartilage
like phantoms. Saline ROIs show an underestimation of the sodium concentration, which reduces as TR increases. Lower
concentrations of agar underestimate the sodium concentrations more like saline, as could be expected.
doi: 10.1371/journal.pone.0073067.g001
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Table 4 summarizes comparisons between the MRI
measures of volume and sodium concentration with the clinical
scoring metrics. Only correlations with |r|≥0.3 are shown. The
patellar ROI’s volume did correlate with pain and KOOS
scoring, and the medial patellar volume also correlated with K-
L score. The sodium concentration over the entire knee
showed a weak relationship (r=0.31) with pain score, as did the
lateral tibial and medial patellar sodium concentrations.
Discussion
This study has shown that T1-weighted sodium MRI can
significantly differentiate knee cartilage in subjects with OA
from age-matched controls without OA symptoms. Previous
pilot studies have compared sodium concentrations, as
determined by MRI, in the knee cartilage of OA subjects and
healthy controls. However there are a number of major
differences to this study. Previous studies concluded that lower
Figure 2.  Example 3D sodium concentration dataset overlaid on the 3D DESS image.  High values of sodium concentration
can be found co-localized with the articular cartilage.
doi: 10.1371/journal.pone.0073067.g002
Table 2. Volume and Sodium Concentrations for each ROI for all 3 visits in each cohort.
 GROUP VISIT WHOLE FEM PAT TIB LF MF LP MP LT MT
Volume  1 19.1 (1.0) 11.5 (0.7) 3.1 (0.2) 4.6 (0.3) 5.9 (0.4) 5.6 (0.4) 1.9 (0.1) 1.2 (0.1) 2.5 (0.1) 2.1 (0.1)
 HC 2 18.6 (1.0) 11.2 (0.7) 3.1 (0.2) 4.4 (0.3) 5.8 (0.4) 5.5 (0.4) 1.9 (0.1) 1.3 (0.1) 2.4 (0.1) 2.1 (0.1)
  3 18.4 (1.0) 11.0 (0.7) 3.0 (0.2) 4.4 (0.2) 5.7 (0.3) 5.3 (0.4) 1.8 (0.1) 1.2 (0.1) 2.4 (0.1) 2.0 (0.1)
  1 19.4 (0.9) 12.6 (0.6) 2.4 (0.1) 4.7 (0.2) 6.3 (0.3) 6.3 (0.4) 1.4 (0.1) 0.9 (0.1) 2.5 (0.1) 2.3 (0.1)
 OA 2 19.5 (0.9) 12.1 (0.7) 2.5 (0.1) 4.5 (0.2) 6.3 (0.3) 5.8 (0.4) 1.6 (0.1) 0.9 (0.1) 2.3 (0.1) 2.2 (0.1)
  3 19.3 (0.9) 12.0 (0.6) 2.5 (0.1) 4.5 (0.2) 6.1 (0.3) 5.9 (0.4) 1.6 (0.1) 1.0 (0.1) 2.3 (0.1) 2.2 (0.1)
[Na]             
  1 318 (12) 258 (14) 307 (12) 310 (13) 330 (12) 267 (16) 250 (13) 295 (14) 321 (12) 318 (12)
 HC 2 326 (12) 265 (14) 321 (12) 318 (13) 334 (12) 272 (16) 256 (13) 312 (14) 336 (12) 326 (12)
  3 316 (12) 257 (13) 321 (11) 309 (13) 328 (12) 260 (15) 252 (12) 309 (14) 340 (12) 316 (12)
  1 343 (11) 281 (13) 345 (11) 347 (12) 340 (11) 279 (14) 282 (11) 355 (13) 337 (11) 343 (11)
 OA 2 349 (11) 284 (13) 344 (11) 361 (13) 344 (11) 289 (15) 283 (12) 365 (14) 335 (11) 349 (11)
  3 332 (11) 286 (13) 340 (11) 341 (12) 326 (11) 293 (14) 277 (11) 360 (13) 335 (11) 332 (11)
Sodium MRI of Cartilage in Osteoarthritis
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Table 3. Summary of statistically significant (p<0.05)
findings from repeated measures ANOVA models within
each ROI.
 Effect Whole knee Fem/Pat/Tib LF/LP/LT/MF/MP/MT
Volume Group - OA<HC in Pat(p=0.0029)
OA<HC in LP (p=0.0046),
MP (p=0.0065)
 Visit - - -
[Na] ROI - {Fem,Tib} > Pat(p<0.0001)
{LF,MF,LT,MT} > {LP,MP}
(p<0.0001)
 Group OA>HC(p=0.019)
OA>HC in Fem
(p=0.038) Pat
(p=0.034) Tib
(p=0.014)
OA>HC in LF (p=0.0014),
LT (p<0.0001), MP
(p=0.0093)
 Visit - - -
denotes no significant findings
sodium values would be found in the diseased cartilage of OA
subjects than in healthy cartilage, as had been identified by in-
vitro cartilage enzymatic degradation studies [7,18,27]. The
seminal study comparing OA and HC subjects’ cartilage in-vivo
[17] used 9 HCs with a mean age of 26 (range 21-31 years)
versus 3 OA subjects with a mean age of 43 (range 38-50
Table 4. Summary of associations between imaging and
clinical measures with |r|≥0.3.
 Whole knee Fem/Pat/Tib
LF/LP/LT/
MF/MP/MT
Volume No significantassociations
Pat: KOOS r =
−0.46, Pain VAS r =
−0.49
LP: KOOS r = −0.52 Pain VAS
r = −0.56, MP: Age r = −0.43,
K-L score r = −0.45, KOOS r =
−0.37, Pain VAS r = −0.38
[Na] Pain VAS r =0.31
No significant
associations
LT: KOOS r = 0.42 Pain VAS r
= 0.44, MP: Pain VAS r = 0.32
Figure 3.  Group means in OA and HC subjects of median sodium concentration at baseline, 3 months and 6 months for
whole, tibial, femoral and patellar cartilage ROIs.  Whiskers denote the standard error of the mean.
doi: 10.1371/journal.pone.0073067.g003
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years). ROIs were specifically drawn in areas of lower sodium
signal for the OA subjects and compared against a whole-
patellar cartilage ROI for HCs. More recent work at 7T
concluded with similar difference in sodium concentration [28].
In that work, both groups contained 5 subjects, though the HC
group had a mean age of 28.7 ± 4.8 years compared to the OA
group’s mean age of 52.4 ± 5.6 years. Although the study’s
stated purpose was not to compare groups, reduced sodium
was reported in one OA subject. Regions of depressed signal
were not specifically delineated, but an ROI was drawn on the
sodium image that bridged the femoral and tibial regions, and
thus included synovial fluid between the regions, and
histograms were compared. In this study, in contrast to
previous studies, the demarcation of ROIs on the sodium
image was specifically avoided due to concerns of biasing the
results towards areas of lower sodium concentration. ROIs
were defined on the independent DESS contrast, and applied
to the coregistered sodium images.
Interestingly, it has been shown that age may be an
independent factor in the decline of sodium MRI signal. Using
an identical setup as the cross-sectional study at 7T [28],
another group has compared [29] a group of 3 young (age
range 20-24 years) to 3 old (age range 43-59) subjects, and
found an average 15% less sodium signal in the older but
otherwise healthy group. Therefore, age-matched groups, as
used here, would be vital to validating sodium MRI in OA. Age-
matched comparisons of sodium MRI in OA have not
previously been reported.
Several groups have noted that the suppression of sodium
signal from fluids surrounding the cartilage may be important in
correctly attributing sodium signal to cartilage. Fluid
suppression via inversion recovery in sodium sequences [13]
can effectively remove the confounding synovial fluid signal,
though at the penalty of reduced SNR in the cartilage signal.
The sodium concentration in the fluid is about half that of the
cartilage, even so, fluid suppression does result in higher
sodium values [16]. The acquisition in this study used a T1-
weighted acquisition, which results in preferential fluid
suppression due to its much longer T1. The short T1 of sodium
in cartilage would result in 28% less signal than using a fully-
relaxed (TR > 5*T1) acquisition, but 74% less sodium signal in
the synovial fluid. The shorter TRs permit more averaging in
the same clinically acceptable scan time, improving SNR. The
SNR efficiency at this TR is 43% higher than that at 100ms TR.
ROIs in this study were defined on the DESS images and
applied to the sodium images. One might expect partial
voluming between the cartilage and fluid to be worse in OA
subject due to thinner cartilage and/or fluid invasion of the
cartilage [30]. This would result in a spuriously lower measured
sodium concentration in OA subjects, the opposite of what was
found. Furthermore, an increased T1 in the diseased cartilage
[18] would also lower the detected sodium concentration, again
opposed to the results. The results presented here show
between a 10 and 20% increase in measured sodium
concentration in the diseased cartilage. If this effect was
entirely a change in the underlying sodium T1 value, the
sodium T1 of the diseased cartilage would need to decrease by
24 to 33%. Only increases in sodium T1 have been noted with
cartilage degradation, however, decreases have been noted in
mechanical compression of ex-vivo cartilage samples [31]. In
this study, care was taken to ensure all subjects had similar
recent activity levels and identical positioning in the MRI
system.
The median sodium concentration in the femoral and tibial
ROIs was greater than the patellar ROI. This is of interest as
the patellar cartilage is the most often studied in sodium MRI of
OA. A surface coil placed on the kneecap is the most common
acquisition setup. This gives very good SNR near the surface
coil, such as in the patellar cartilage, but poor SNR in regions
further away, such as the femoral condyles. This study used a
volume sodium coil, which results in lower maximum SNR in
any one region, but more homogenous transmit and receive RF
profiles, reducing the need for their correction, and giving more
equal sensitivity to all areas within the coil. Sodium transmit RF
mapping performed during study setup indicated very low
variation across the volume; therefore no RF mapping was
performed in this study. However, all subjects were carefully
positioned to ensure the bulk of the knee cartilage was in the
center of the coil, as far away as possible from the RF coil
rungs, where the RF field often varies.
Clinical measures for the patient population were in line with
expectations as clear differences were found between OA
subjects and healthy controls in three clinical measures:
KOOS, Pain VAS and KL score. The use of age-matched
subjects brings concerns about the relative health of the
cartilage in knees of subjects in the 60’s. Therefore, to rule out
clinically occult radiographic changes, subjects were re-
stratified into OA and HC groups based on their KL scores,
defining a KL score of 0 or 1 as HC and a KL score of 2 or
greater as OA. After re-stratifying, significant separation of the
groups remained in all measures that achieved significance
with the previous classification, with OAs continuing to have
higher sodium concentration in all compartments (data not
shown).
There are a number of important limitations to the
interpretation of this study. Primarily, no histological sampling
of the cartilage was performed, so no comparison between
disease state and sodium concentration can be made. The
differences in relative changes between these clinical results
and previous preclinical or ex-vivo models may reflect inherent
limitations of those latter acute models to reproduce key
features of the chronic human disease. However, without
histological verification, no conclusions can be drawn. As this
study employed T1-weighted sodium MRI, rather than density-
weighted sodium MRI, the increased sodium concentration
detected could not be differentiated from a shortening of the
T1. However, previous studies have shown T1 increases with
disease, rather than decreases. The 3T magnetic field strength
used here limits sensitivity and resolution, possibly contributing
to smaller effect sizes than could be achieved from ultra-high
field (e.g. 7T) studies. The number of subjects used here was
designed to power a 3T study due to the greater availability of
3T scanners. Finally, all ROI’s were drawn by a single blinded
reader, therefore no inter-reader statistics can be examined.
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Conclusions
The overall goal of this study was to validate sodium MR
imaging measures of cartilage for use in clinical trials of
disease-modifying drugs. Previous reports show good
reproducibility of 3.2% within-subject coefficient of variation [32]
for sodium MRI in the knee cartilage. This study shows clear
differences between OA subjects and healthy controls,
although no change was seen over the defined timespan of 6
months.
This study has compared age-matched cohorts of OA and
healthy control subjects using sodium MRI for the first time. T1-
weighted sodium MRI significantly differentiated OA subjects
from healthy controls. This difference was stable over the 6
month timeframe. Volumes of the ROIs were also compared,
and patellar volume was seen to be lower with strong statistical
significance in OA subjects. Volume was not noted to change
over the 6 month time frame; however, it was unlikely to be
detected over this timespan, as most structural studies use
longer timespans [33].
The results of this study can be used to design and power a
clinical trial of a disease modifying intervention for OA. It can
be seen that sodium MRI on a 3T scanner can significantly
differentiate between knee cartilage in healthy controls and that
in subjects with previously-diagnosed OA. However, the
timescales needed for such a study are longer than 6 months.
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